Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Cougar Biotechnology (CGRB)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CGRB
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Biotech: Q3 Market Update
R. Scott Raynovich
•
Oct 16
•
Comment!
OncoGenex: Room for Further Growth?
EP Vantage
•
Oct 08
•
Comment!
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
Michael Becker
•
Jun 19
•
6 Comments
Biotech Stocks and the ASCO-Effect
Michael Becker
•
Jun 01
•
2 Comments
Big Pharma's Pheeding Phrenzy
Mike Huckman
•
May 28
•
Comment!
Access Pharma: A Smallcap Cancer Biotech Call Option Trade
Mike Havrilla
•
May 28
•
13 Comments
More articles on CGRB »
Cramer
Cramer's Mad Money - Beating the Bad News Bears (3/13/09)
Mon March 16, 2009
More Cramer on CGRB »
Instablogs
Healthcare companies still desperate for a partner
Tue June 30, 2009
•
EP Vantage
•
4 Comments
Molecular Insight Pharmaceuticals: In the Prostate Cancer Spotlight
Thu June 18, 2009
•
Michael Becker
•
Comment!
Biotech Stocks and the ASCO-effect
Sun May 31, 2009
•
Michael Becker
•
Comment!
Write a post on CGRB
|
More Instablogs on CGRB »
Sentiment
What advice would you give to
CGRB?
123 characters left
What's your view of CGRB?
Make sure you include CGRB
140 characters left
|
Settings